Glofitamab in Chinese Patients With R/R DLBCL — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Glofitamab in Chinese Patients With R/R DLBCL — Stella

Home/DLBCL - Diffuse Large B Cell Lymphoma/

View on ClinicalTrials.gov

Recruiting

Back to DLBCL - Diffuse Large B Cell Lymphoma trials

Trial locations(1 site)

China

Peking Union Medical College Hospital, Beijing, Beijing Municipality

Key details

Sponsor

Peking Union Medical College Hospital

Enrollment target

~20 participants

Started

January 2024

Primary completion

December 2027

Age range

18 Years – 80 Years

Last updated March 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.